MedImmune Targets 5 PDL Patents In Licensing Spat

Law360, New York (December 18, 2008, 12:00 AM EST) -- MedImmune LLC is seeking the invalidation of five patents owned by PDL BioPharma Inc. as part of a licensing fight over a respiratory drug for infants and a related product that has not yet been released.

In a complaint filed Tuesday in the U.S. District Court for the Northern District of California, MedImmune asked for a declaratory judgment that the patents are invalid and that it owes no payments to PDL under a patent license agreement reached by the companies in 1997.

For now, though, MedImmune...
To view the full article, register now.